Parkinson's disease (PD) results primarily from the death of dopaminergic neurons in the
substantia nigra. Current PD medications treat symptoms; none halt or retard dopaminergic …

Parkinson's disease (PD) is characterized by the progressive loss of dopaminergic neurons
in the substantia nigra leading to the major clinical and pharmacological abnormalities of …

Parkinson disease (PD) is a complex neurodegenerative disorder with both motor and
nonmotor symptoms owing to a spreading process of neuronal loss in the brain. At present …

Parkinson's disease (PD) is a common and incurable neurodegenerative disease, affecting
1% of the population over the age of 65. Despite a well-described clinical and pathological …

Several factors are known to be capable of inducing relatively selective dopaminergic cell
death in the substantia nigra and inducing the clinical features that characterize Parkinson's …

Parkinson's disease (PD) is a progressive neurodegenerative movement disorder that
results primarily from the death of dopaminergic neurons in the substantia nigra. Although …

Significance: Parkinson's disease (PD) is a neurodegenerative disorder characterized, in
part, by the progressive and selective loss of dopaminergic neuron cell bodies within the …

Parkinson's disease (PD) is a neurodegenerative disorder that affects about 1.5% of the
global population over 65 years of age. A hallmark feature of PD is the degeneration of the …

Parkinson's disease (PD) is a common age-related, progressive neurodegenerative disease
of unknown etiology. Environmental factors have long been suspected to participate in the …

Parkinson's disease (PD) is a complex disease, with genetics and environment contributing
to the disease onset. Recent studies of causative PD genes have confirmed the involvement …